Intensity-Modulated Radiation Therapy for Clinically Localized Prostate Cancer
The goal of the following chapter is to discuss the role of intensity-modulated radiation therapy (IMRT) for clinically localized prostate cancer. We review the important aspects of patient selection for this therapeutic modality as well as discuss the relevant published literature on dose escalation. Additionally, a comprehensive review of techniques and delivery of treatment are presented. Finally, we discuss both the potential acute and late toxicities associated with IMRT.
KeywordsDose Escalation Planning Target Volume Dose Distribution External Beam Radiation Therapy Fiducial Marker
- Vora SA, Wong WW, Schild SE et al (2007) Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 68:1053–1058PubMedCrossRefGoogle Scholar
- Zelefsky MJ, Pei X, Teslova T et al (2012b) Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention. BJU Int 110:1696–1701PubMedCrossRefGoogle Scholar
- Zietman AL, Bae K, Slater JD et al (2010) Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09. J Clin Oncol 28:1106–1111PubMedCentralPubMedCrossRefGoogle Scholar